NCT00450229View on ClinicalTrials.gov

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Adenocarcinoma of the ProstateProstate CancerStage I Prostate CancerStage II Prostate Cancer
Interventions
DRUG

diindolylmethane

Given PO

DRUG

placebo

Given PO

PROCEDURE

therapeutic conventional surgery

Undergo surgical resection

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00450229 - Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter